Diagnostic Imaging Collaboration and Licensing Agreements Analysis Report 2025 with Directory of 658 Deals Signed Since 2016 by Company A-Z, Deal Type, and Therapy Area - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.

This report contains a comprehensive listing of 658 diagnostic imaging deals announced since 2016, including financial terms where available, and incorporates links to online deal records of actual diagnostic imaging partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents submitted to the Securities Exchange Commission by companies and their partners.

Fully revised and updated, the report provides details of diagnostic imaging deals from 2016 to 2025. The report provides a detailed understanding and analysis of how and why companies enter diagnostic imaging deals. These deals tend to be multicomponent, starting with collaborative R&D and commercialization of outcomes. The report includes collaboration, development, research, and licensing deals.

The initial chapters of this report offer an orientation of diagnostic imaging dealmaking. Chapter 1 introduces the report, followed by Chapter 2, which gives an overview of trends in diagnostic imaging dealmaking since 2016. Chapter 3 lists leading diagnostic imaging deals by headline value. Chapter 4 includes a comprehensive listing of the top 25 most active companies in diagnostic imaging dealmaking, along with a summary and public domain contract documents. Chapters 5 and 6 provide detailed reviews of diagnostic imaging deals and partnering deals, respectively, categorized by technology focus since January 2016.

The report also includes numerous tables and figures that illustrate the trends and activities in diagnostic imaging deal making since 2016.

In addition, a comprehensive deal directory is provided, organized by company A-Z, deal type, and therapeutic target. Each deal title links via Weblink to an online version of the deal record and, where available, the contract document, providing easy access to each contract document on demand.

Diagnostic Imaging Collaboration and Licensing Deals provides the reader with the following key benefits:

• Understand deal trends since 2016
• Browse diagnostic imaging collaboration and licensing deals
• Benchmark analysis - identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, deal type, and therapy area
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess the suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Diagnostic Imaging Collaboration and Licensing Deals includes:

• Trends in diagnostic imaging dealmaking in the biopharma industry
• Directory of diagnostic imaging deal records covering pharmaceutical and biotechnology
• The leading diagnostic imaging deals by value
• Most active diagnostic imaging licensing dealmakers

Analyzing contract agreements allows due diligence of:

• What are the precise rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in diagnostic imaging dealmaking

2.1. Introduction

2.2. Diagnostic imaging deals over the years

2.3. Most active diagnostic imaging dealmakers

2.4. Diagnostic imaging deals by deal type

2.5. Diagnostic imaging deals by therapy area

2.6. Diagnostic imaging deals by industry sector

2.7. Deal terms for diagnostic imaging deals

2.7.1 Diagnostic imaging deals headline values

2.7.2 Diagnostic imaging deal upfront payments

2.7.3 Diagnostic imaging deal milestone payments

2.7.4 Diagnostic imaging royalty rates

Chapter 3 - Leading diagnostic imaging deals

3.1. Introduction

3.2. Top diagnostic imaging deals by value

Chapter 4 - Most active diagnostic imaging dealmakers

4.1. Introduction

4.2. Most active diagnostic imaging dealmakers

4.3. Most active diagnostic imaging deals company profiles

Chapter 5 - Diagnostic imaging contracts dealmaking directory

5.1. Introduction

5.2. Diagnostic imaging contracts dealmaking directory

Chapter 6 - Diagnostic imaging dealmaking by technology type

Companies Featured

• 3B Pharmaceuticals
• 3Derm Systems
• Abbott Laboratories
• Abcam
• AC Immune
• Actelion
• AdAlta
• Advanced Chemistry Development
• Agilent Technologies
• Aidoc
• Akoya Biosciences
• Alector
• Alfasigma
• Alnylam Pharmaceuticals
• Alzheimer's Drug Discovery Foundation
• Amag Pharmaceuticals
• American College of Cardiology
• AMRA
• AstraZeneca
• Banner Health
• Bayer
• Beckman Coulter
• Bio-Techne
• BioArctic AB
• Biogen
• Boston Scientific
• Brigham and Women's Hospital
• Carl Zeiss
• Celgene
• Cleveland Clinic
• CorTechs Labs
• Elekta
• Fujifilm
• GE Healthcare
• Guardant Health
• Harvard Medical School
• IBM Watson Health
• iCAD
• Illumina
• Johnson & Johnson
• Konica Minolta
• Lantheus Medical Imaging
• Massachusetts General Hospital
• Medtronic
• Microsoft
• Nvidia
• Pfizer
• Philips
• Roche
• Siemens Healthineers

For more information about this report visit https://www.researchandmarkets.com/r/z4df6c

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.